IP Library Granted Patent US 8,642,767
Granted Patent B2
US 8,642,767 · App. 13/256,722 · Granted Feb 4, 2014

Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof

Inventors: Silvano Spinelli (Milan, IT); Valeria Livi (Milan, IT)
Assignee: EOS Ethical Oncology S.p.A. Abbreviated Form EOS S.p.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,767
App. No.
13/256,722
Granted
Feb 4, 2014
Kind
B2
Abstract

A process for the preparation in high yields and purity of the compound 6-(7-4(1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.

Claims (11)

1. Process for the preparation of the compound 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I):

or a pharmaceutically acceptable salt thereof, comprising reacting a compound of formula (VI):

wherein R and R′ taken together with the nitrogen atom they are linked to represent a protected primary amino group, with a compound of formula (XVI):

wherein X is selected from Cl, Br or I in the conditions of the Mitsunobu reaction, to obtain a compound of formula (XII):

wherein X,R and R′ are as defined above.

2. The process of claim 1 wherein in the compound of formula (VI) R′is hydrogen and R is selected from the group consisting of benzyl optionally substituted on the aromatic ring with up to three substituents selected from the group consisting of halogen, cyano, trifluoromethyl;C 1 -C 3 acyl, C 7 -C 11 aroyl, C 1 -C 3 alkylsulfonyl, C 6 -C 10 arylsulfonyl, C 1 -C 4 alkoxycarbonyl, benzyloxycarbonyl optionally substituted on the aromatic ring with up to three substituents selected from the group consisting of halogen, cyano, trifluoromethyl.

3. The process of claim 2 wherein R is selected from the group consisting of benzyl, acetyl, benzoyl, trifluoromethanesulfonyl, benzenesulfonyl,p-toluenesulfonyl, methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, allyloxycarbonyl, benzyloxycarbonyl.

4. The process of claim 1 wherein in the compound of formula (VI) R′ is tri (C 1 -C 3 alkyl)silyl and R is C 1 -C 4 alkoxycarbonyl or benzyloxycarbonyl optionally substituted on the aromatic ring with up to three substituents selected from the group consisting of halogen, cyano, trifluoromethyl.

5. The process of claim 4 wherein R is tert-butoxycarbonyl.

6. The process of claim 1 wherein in the compound of formula (VI) R and R′ together with the nitrogen atom they are linked to form a phthalimido group.

7. The process of claim 1 wherein in the compound of formula (XVI) X is chlorine.

Assignments (2)
CHANGE OF NAME Recorded Jan 15, 2015
From: EOS ETHICAL ONCOLOGY SCIENCE S.P.A ABBREVIATED FORM EOS S.P.A
To: CLOVIS ONCOLOGY ITALY S.R.L.
Reel/Frame 034724/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2011
From: SPINELLI, SILVANO; LIVI, VALERIA
To: EOS ETHICAL ONCOLOGY SCIENCE S.P.A ABBREVIATED FORM EOS S.P.A
Reel/Frame 026911/0116 →
Priority Claims (1)
IT MI2009A0397 · Mar 16, 2009 · national
Continuity (1)
Related Publication 20120010415A1 · Jan 12, 2012